Drug intelligence / Profile preview

arginine glutamate

Development stage
Unknown
Lead developer
Furen Pharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Arginine glutamate is a pharmaceutical combination consisting of the amino acids L-arginine and L-glutamic acid, typically administered as a salt. It is primarily indicated for the treatment of hyperammonemia and hepatic encephalopathy associated with chronic liver diseases such as cirrhosis. The drug works through a dual mechanism to detoxify ammonia: L-arginine serves as a critical intermediate in the urea cycle, promoting the conversion of toxic ammonia into urea in the liver, while L-glutamic acid reacts with ammonia to form glutamine via the action of glutamine synthetase, providing an alternative pathway for ammonia removal in the brain and peripheral tissues. Furen Pharmaceutical Group is a prominent developer and manufacturer of this combination in China, where it is widely used in clinical practice for liver-related metabolic disturbances.

Brand names
Arginine Glutamate Injection
Other names
L-Arginine L-glutamateArginine-glutamic acid saltGlutamate arginine
02

Targets

ARG1 (Arginase 1)GLUL (Glutamine synthetase)

Beyond the preview

Go deeper on arginine glutamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arginine glutamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call